Viewing Study NCT00675857


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-29 @ 12:03 PM
Study NCT ID: NCT00675857
Status: COMPLETED
Last Update Posted: 2010-08-24
First Post: 2008-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Sponsor: Bellus Health Inc. - a GSK company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module